肥胖中的蛋白基因酶,以及基因酶向治疗
Atilla Engin1,2
1Faculty of Medicine, Department of General Surgery, Gazi University, Besevler, Ankara, Turkey. dr.aengin@gmail.com.
Advances in experimental medicine and biology
|September 17, 2024
概括
蛋白激酶和酸酶调节生理反应,双特异性酸酶通过影响胰岛素信号传递,在肥胖中发挥关键作用. 针对这些途径的疗法,如甲福明和利拉格卢提德,在缓解与肥胖相关的代谢功能障碍方面表现有前途.
科学领域:
- 生物化学 生物化学
- 细胞生物学 细胞生物学
- 代谢障碍 代谢障碍 代谢障碍
背景情况:
- 蛋白激酶和酸酶对于生理过程至关重要,表现出基质特异性和调节机制.
- 双特异性酸酶是参与细胞过程和肥胖的关键信号转导酶,通常会通过JNK等途径损害胰岛素信号传递.
- 肥胖与葡萄糖代谢受损,胰岛素耐药性,氧化应激和内分泌网膜 (ER) 应激有关,涉及AMPK,mTOR和PKC等激酶.
研究的目的:
- 探索蛋白激酶和酸酶在肥胖和相关代谢功能障碍中的作用.
- 研究这些酶影响胰岛素信号传递,脂毒性和肥胖中氧化应激的机制.
- 评估针对这些途径的药理干预措施在管理肥胖及其并发症方面的潜力.
主要方法:
- 关于肥胖中蛋白激酶和酸酶信号的文献综述.
- 分析特定激酶 (JNK,AMPK,mTOR,PKC) 和酸酶在胰岛素抵抗和代谢调节中的参与.
- 检查药理学剂 (nifedipine,metformin,liraglutide,berberine,rapamycin) 对与肥胖相关的途径的影响.
主要成果:
- 肥胖症中胰岛素信号受损与kappa B-激酶β和JNK的激活抑制剂有关,这些受氧化和ER压力激活.
- 像CaMKII/p38这样的肥胖激活激酶通过通过ER压力激活ATF-4来抑制胰岛素信号传递.
- 甲福明和利拉格卢提德等药理学药物通过调节AMPK,mTOR和氧化应激通路来减轻脂毒性和胰岛素耐药性的潜力.
结论:
- 蛋白激酶和酸酶是代谢调节和肥胖的功能障碍的核心.
- 针对特定的信号通路,例如涉及AMPK,mTOR和压力反应的信号通路,为肥胖和相关的胰岛素抵抗提供了治疗潜力.
- 药理干预措施,如甲福明和利拉格卢提德,在减轻肥胖引起的代谢损伤和改善胰岛素敏感性方面表现有前途.
关键词:
5′-腺单酸盐 (AMP) 激活的蛋白激酶 (AMPK)具有双重特异性的激酶.细胞外信号调节的蛋白激酶 (ERK)卡帕B-激酶 (IKK) 的抑制剂脂质亡 (Lipoapoptosis) 是一种致死性的疾病.肝激酶B1 (LKB1) 是一种肝激酶.MAPK 酸酶的使用方法猛素的哺乳动物标 (mTOR)甲基因激活蛋白激酶 (MAPK) 是一种中基因激活蛋白激酶.周期 (Per) - 亚利碳化合物受体核转位器 (ARNT) - 专注的蛋白质 (Sim) (PAS) 激酶 (PASK).蛋白激酶B (PKB; Akt) 是一种蛋白质激酶.类似蛋白质激酶的内 плазма网膜 (ER) 中的真核启动因子-2α激酶 (PERK)蛋白质激酶酶是一种蛋白质激酶.蛋白质酸酶是一种蛋白质酸酶.c-Jun N-终端激酶 (JNK) 的使用相关概念视频
Protein Kinases and Phosphatases
13.1K
Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
13.1K
PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K
Transducer Mechanism: Enzyme-Linked Receptors
2.4K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.4K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
cAMP-dependent Protein Kinase Pathways
6.2K
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
6.2K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K


